<code id='13AD75EBAB'></code><style id='13AD75EBAB'></style>
    • <acronym id='13AD75EBAB'></acronym>
      <center id='13AD75EBAB'><center id='13AD75EBAB'><tfoot id='13AD75EBAB'></tfoot></center><abbr id='13AD75EBAB'><dir id='13AD75EBAB'><tfoot id='13AD75EBAB'></tfoot><noframes id='13AD75EBAB'>

    • <optgroup id='13AD75EBAB'><strike id='13AD75EBAB'><sup id='13AD75EBAB'></sup></strike><code id='13AD75EBAB'></code></optgroup>
        1. <b id='13AD75EBAB'><label id='13AD75EBAB'><select id='13AD75EBAB'><dt id='13AD75EBAB'><span id='13AD75EBAB'></span></dt></select></label></b><u id='13AD75EBAB'></u>
          <i id='13AD75EBAB'><strike id='13AD75EBAB'><tt id='13AD75EBAB'><pre id='13AD75EBAB'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:entertainment    Page View:261
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more
          Medical mystery: When a cough is not just a cough
          Medical mystery: When a cough is not just a cough

          MollyFergusonforSTATWhenCherylDaiglestartedcoughinginFebruary2013,shechalkedituptothesneezingandsnif

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          The Readout: Gilead, Bernie Sanders, and other pharma news

          YichuanCao/SipaUSAWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechn